WARNER-LAMBERT CEREBYX (FOSPHENYTOIN) WILL BE AVAILABLE IN SEPTEMBER; I.V. DILANTIN TO BE DISCONTINUED AT YEAR-END: CEREBYX PRICED AT PREMIUM TO DILANTIN
Executive Summary
Warner-Lambert will launch Cerebyx (fosphenytoin injection) in September following FDA's Aug. 5 approval of the Dilantin prodrug.